Metformin in Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.
Also called NCT02252081
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 125 participants
- Registry
-
NCT02252081
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02252081. Randomized; quadruple masking; primary purpose treatment. Start 2014-10-01 (actual); primary completion 2019-12-31 (actual). Results posted on 2021-11-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Metformin in Kidney Disease
- Condition
- Chronic Kidney Disease
- Condition
- Cardiovascular Disease
- Condition
- Metabolic Syndrome
- Intervention (Drug)
- metformin
- Intervention (Drug)
- Placebo
- Lead sponsor
- VA Office of Research and Development
Record details
- Record id
cardio:ct-nct02252081- Content hash
ceaa095e831c57c3760820b80b450a214563a078406db053e754641c1b21f269